^MALVERN, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) — YPrime
(http://www.yprime.com/), a trusted clinical technology provider
Studies, published today new results showing that the use of
AI achieves measurable quality improvements in the process of eCOA localization –
with 74% fewer migration errors, two-thirds shorter review cycles and
higher global student inclusion.
The one at ISPOR 2025 by Jonathan Norman, Director of Localization & Scale
Management at YPrime, presented study?Garbage In, Garbage Out: Can AI
Reduce the Impact of Human Error in eCOA Localized Text Migration?
(https://www.yprime.com/ai-driven-ecoa-localization-speed-accuracy/)”
examined how AI can address one of the most overlooked aspects of eCOA
Development can improve: migration. This is the process
importing translated Clinical Outcome Assessments (COAs) into digital systems.
YPrime compared a sample of 15 studies in 11 languages
Migration carried out exclusively by humans with the in-house AI
supported migration process. The AI workflow reduced the total number
Migration errors by 74%, reduced the number of incorrect screen reports
by 60% and shortened the localization review process by 67%, with no new ones
Introduce error types.
?Localization is one of the most important – and least automated
– Steps for the global readiness of a study,” said Dr. Karl
McEvoy, Vice President, eCOA and Patient Technologies at YPrime.?This
Research shows that AI when applied to eCOA-specific file structures and
Language rules are trained and can eliminate the most error-prone steps.
This provides linguists and study teams with higher quality
Materials for review. The result is faster, cleaner releases
Data and more inclusive global studies.”
By improving the speed and accuracy of localization
AI enables sponsors to maintain broader language coverage. Through this
Reduces the need to narrow down underrepresented populations
Exclude schedules. Faster release of localized screen reports
enables earlier start of eCOA study builds and first-patient-in-
Milestones, resulting in measurable time and cost benefits for global programs
leads.
The results of this study underscore YPrime’s ongoing commitment
for innovations that deliver measurable efficiency gains in studies. To the
Recent market launches include Advanced eCOA Oversight
(https://www.yprime.com/yprime-advanced-ecoa-oversight/), Automated Data Change
Forms (https://www.yprime.com/yprime-releases-reimagined-ecoa-automated-data-
change-form-for-more-efficient-clinical-trial-data-management/) (DCF) and
Glucometer integrations (https://www.yprime.com/yprime-ecoa-dcf-improves-
clinical trial data management/) for connected device studies. YPrime expanded
continues its AI initiatives within the YPrime eCOA platform, with a focus on
Quality scoring and next-generation localization workflows, automation
balance with human control.
YPrime was recently featured in the?eCOA PEAK Matrix (https://www.yprime.com/yprime-ecoa-
peak-matrix-2025-everest-group/)(®) (https://www.yprime.com/yprime-ecoa-peak-
matrix-2025-everest-group/) Assessment 2025 (https://www.yprime.com/yprime-ecoa-
“peak-matrix-2025-everest-group/)” of the Everest Group was honored as a “Leader”.
This recognizes the company’s proven ability to deliver scalable,
to deliver high quality eCOA solutions that meet the needs of modern clinical
studies in terms of speed and complexity. In addition, that was
Company 2024 as?Trailblazer in Patient Engagement
(https://www.yprime.com/yprime-recognized-as-trailblazer-in-patient-engagement-
by-everest-group/)” and was thus recognized for his commitment,
to develop digital tools that enable access, accuracy and equality in
improve clinical research.
YPrime experts will report these results on Wednesday, December 3, 2025
present in a webinar. For more information, see
www.yprime.events. The full ISPOR poster is on the website
www.yprime.com/resources available.
About YPrime
YPrime simplifies clinical trials with eCOA, IRT and eConsent solutions that
Combine speed, flexibility and quality. The eCOA platform from
YPrime improves patient compliance through an intuitive application and
A user-friendly design streamlines on-site workflows
a powerful eCOA portal that integrates seamlessly into networked devices
and supports sponsors with dashboards for better decisions. The AI
eCOA-powered localization accelerates globalization while
Pre-validated and configurable eCOA and IRT solutions provide faster
Enable study start with quality metrics above industry standards. YPrime
is trusted by both leading pharmaceutical companies and emerging ones
Biotech companies and combines in-depth industry expertise with innovation
to deliver reliable solutions. With almost two decades of evidence
Successes, solutions in over 250 languages and support in more than 100 countries
YPrime is your partner for reliably managing clinical problems
Research challenges. Visit www.yprime.com or send an email
Email [email protected] (mailto:[email protected]).
Media contact
Grace Mohren
Senior Vice President, Marketing, YPrime
You can find a photo of this announcement
at: https://www.globenewswire.com/NewsRoom/AttachmentNg/c3d3b4f4-d80f-
4cc1-8051-78e3de911804
°